Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide "For Research Purposes".
繞過開處方醫師和藥劑師:線上購買 Semaglutide 和 Tirzepatide「用於研究目的」。
Ann Pharmacother 2024-09-17
Administration errors of compounded semaglutide reported to a poison control center-Case series.
複合式semaglutide的管理錯誤報告給毒物控制中心-案例系列。
J Am Pharm Assoc (2003) 2024-04-18
Evaluating the Efficacy and Pharmacoeconomics of Semaglutide and Tirzepatide in the Setting of Obesity.
評估塞麥谷肽和特爾澤帕肽在肥胖症治療中的療效和藥物經濟學。
Am J Ther 2023-07-18
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset.
Semaglutide 濫用的風險:聚焦於美國食品藥物管理局 FDA 不良事件報告系統 (FAERS) 藥物警戒資料集。
Pharmaceuticals (Basel) 2023-08-01
Social Media as Pharmacovigilance: The Potential for Patient Reports to Inform Clinical Research on Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists for Substance Use Disorders.
社群媒體作為藥物警戒:患者報告對於關於胰高血糖素樣肽-1(GLP-1)受體激動劑在物質使用障礙臨床研究的潛力。
J Stud Alcohol Drugs 2024-02-10
Impact of semaglutide and dulaglutide shortages on Pharmaceutical Benefits Scheme prescriptions supplied for type 2 diabetes treatment.
Semaglutide 和 Dulaglutide 短缺對供應給予第二型糖尿病治療的藥物福利計劃處方的影響。
Aust J Gen Pract 2024-02-07
Challenges with glucagon-like peptide-1 (GLP-1) agonist initiation: a case series of semaglutide overdose administration errors.
GLP-1激素類似物(GLP-1)激動劑初始治療的挑戰:一系列關於塞麥格魯齊過量使用錯誤的病例。
Clin Toxicol (Phila) 2024-03-22
An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database.
基於真實世界數據的 Semaglutide 安全性評估:從普及度到歐盟藥品不良反應資料庫的自發性報告。
Biomedicines 2024-05-25
Semaglutide and health risk: Development and validation of a LC-HRMS method for testing semaglutide in whole blood and application to real cases.
Semaglutide與健康風險:全血中測試Semaglutide的LC-HRMS方法的開發與驗證,並應用於真實案例。
J Chromatogr B Analyt Technol Biomed Life Sci 2024-06-16